Trials and PIsView all posts »
PEARL HF with Dr Bertram PittAug 29, 2010 09:55 EDT
Dr Bertram Pitt (University of Michigan, Ann Arbor) discusses PEARL HF: a multicenter, randomized, double-blind, placebo-controlled, parallel-group, multiple-dose study to evaluate the effects of RLY5016 in heart-failure patients.
Recorded at the ESC convention center in Stockholm, Sweden on Sunday, August 29.
PEARL-HF: New potassium-binding resin reduces hyperkalemia in heart failure